Pharmaceutical News

RSS

TOLMAR, Impax Labs partner for alternative dosage form products

Impax Laboratories, Inc. and TOLMAR, Inc. today announced that they will collaborate on a multiproduct agreement for the development, supply and distribution of alternative dosage form products.

26 Mar 2012

OSI Systems receives FDA clearance for Arkon anesthesia delivery system

OSI Systems, Inc., a vertically-integrated provider of specialized electronic products for critical applications in the Security and Healthcare industries, today announced that its Healthcare division, Spacelabs Healthcare, received clearance under Section 510(k) from the U.S. Food and Drug Administration to market the Arkon high-performance anesthesia delivery system.

26 Mar 2012

Rifaximin and lubiprostone offer best options for patients with IBS

Cedars-Sinai researchers have determined that two prevalent drug therapies - rifaximin and lubiprostone - offer some of the best options for treating irritable bowel syndrome, a widespread disorder that affects up to one in five Americans.

26 Mar 2012

USPTO issues patent to Inovio's SynCon H1N1 influenza vaccine

Inovio Pharmaceuticals, Inc. announced today that the United States Patent and Trademark Office granted U.S. Patent No. 8,133,723, covering Inovio's SynCon universal vaccine related to H1N1 influenza.

26 Mar 2012

Bacteriophages can tackle drug-resistant bacterial infections

Viruses that can target and destroy bacteria have the potential to be an effective strategy for tackling hard-to-treat bacterial infections. The development of such novel therapies is being accelerated in response to growing antibiotic resistance, says Dr David Harper at the Society for General Microbiology's Spring Conference in Dublin.

26 Mar 2012

Obese or overweight women may have increased risk of breast cancer recurrence

Women who are overweight or obese when they are diagnosed with breast cancer are at higher risk of cancer recurrence or related death than are leaner women, according to a new study to be presented to the 8th European Breast Cancer Conference.

26 Mar 2012

Metformin can have protective effects on the heart

The widely used diabetes medicine metformin can have protective effects on the heart, reveals a new study conducted at the Sahlgrenska Academy, at the University of Gothenburg, Sweden.

26 Mar 2012

FDA Advisory Committee to review Repligen's SecreFlo NDA on May 31

Repligen Corporation today announced that the U.S. Food and Drug Administration's Gastrointestinal Drugs Advisory Committee will meet on May 31, 2012 to discuss the Company's New Drug Application (NDA) for SecreFlo for the improved detection of pancreatic duct abnormalities in combination with magnetic resonance imaging (MRI) in patients with pancreatitis.

26 Mar 2012

Nerve pain patients in Wales gain access to first of a kind treatment which can provide lasting pain relief

For the first time NHS patients in Wales with peripheral nerve pain (known as peripheral neuropathic pain) can be treated with a patch containing capsaicin, which can provide at least 12 weeks pain relief following a single 30- or 60-minute application.

25 Mar 2012

57% of Australians make mistakes with their medicines

New research from NPS has found that 57% of Australians report they have made a mistake with their medicines in the past 12 months.

25 Mar 2012

Ibuprofen may be used effectively for altitude sickness: Study

Altitude sickness manifests by symptoms including a headache, fatigue, dizziness and sometimes nausea and vomiting. In addition, patients most likely also feel like they are working harder to breathe, like they are constantly trying to catch their breath. It normally takes days to weeks to fully acclimate to a higher altitude. It affects between 25 percent and 40 percent of the population and can be debilitating.

25 Mar 2012

New cholesterol lowering drugs on the horizon

The new drugs in development by pharmaceutical makers are injectable medications that block a protein called PCSK9. These drugs have shown promise in early clinical trials for slashing bad LDL cholesterol further than widely used statins can alone. Their biggest advocates say PCSK9 blockers have the potential to be the next multibillion-dollar class of heart drugs.

25 Mar 2012

Lawmakers examine how Medicare, Medicaid can help stop prescription painkiller abuse

Lawmakers held a hearing Thursday on what steps the federal government can take to help prevent the abuse of prescription painkillers.

23 Mar 2012

Aternative pain medication without narcotics safe after sinus surgery

Patients who have undergone sinus surgery can safely take an alternative pain medication that does not cause the side effects of narcotics such as fentanyl and Vicodin, a Loyola University Health System study has found.

23 Mar 2012

Africa must develop its own pharmaceutical pipeline through creation of policy frameworks

"To break free of its dependence on donor money and supplies from India, Africa must develop its own pharmaceutical pipeline by creating policy frameworks that encourage a fledgling drug industry," journalist Priya Shetty argues in this SciDev.Net opinion piece.

23 Mar 2012

European Commission grants marketing authorization for use of BYETTA with basal insulin

Amylin Pharmaceuticals, Inc. and Eli Lilly and Company announced today that the European Commission has granted marketing authorization to BYETTA (exenatide twice-daily) as an adjunctive therapy to basal insulin, with or without metformin and/or Actos (pioglitazone), for the treatment of type 2 diabetes in adults who have not achieved adequate glycemic control with these agents.

23 Mar 2012

Pharmaceutical News

TOLMAR, Impax Labs partner for alternative dosage form products

OSI Systems receives FDA clearance for Arkon anesthesia delivery system

Rifaximin and lubiprostone offer best options for patients with IBS

USPTO issues patent to Inovio's SynCon H1N1 influenza vaccine

Bacteriophages can tackle drug-resistant bacterial infections

Obese or overweight women may have increased risk of breast cancer recurrence

Metformin can have protective effects on the heart

FDA Advisory Committee to review Repligen's SecreFlo NDA on May 31

Nerve pain patients in Wales gain access to first of a kind treatment which can provide lasting pain relief

57% of Australians make mistakes with their medicines

Ibuprofen may be used effectively for altitude sickness: Study

New cholesterol lowering drugs on the horizon

Lawmakers examine how Medicare, Medicaid can help stop prescription painkiller abuse

Aternative pain medication without narcotics safe after sinus surgery

Africa must develop its own pharmaceutical pipeline through creation of policy frameworks

European Commission grants marketing authorization for use of BYETTA with basal insulin

No added benefit of aliskiren-amlodipine fixed drug combination for hypertension

Lawmakers allege some drug companies inflate cost of scarce drugs with 'fake pharmacies'

tAI could predict sensitivity to chemotherapy in patients with triple-negative breast cancer

Verapamil drug may reverse diabetes-related death of pancreatic beta cells

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News